Sign in

Kimberly Luddy

@kimberly-luddy.bsky.social
634 followers 411 following 22 posts

Theoretical and experimental immunologist working in cancer research. Moffitt Cancer Center

PostsRepliesMedia
Reposted by Kimberly Luddy
Nature Reviews Cancer @natrevcancer.nature.com · 18/09/2026
#Review🚨 Read how genotype and phenotype co-evolve during cancer progression with insights from single-cell multimodal technologies and phylogenetic approaches, revealing vulnerabilities in mutant clones. @landau.bsky.social 📖👇
dlvr.it
A single-cell lens into the co-evolution of genotypes and phenotypes in cancer - Nature Reviews Cancer
In this Review, Izzo et al. discuss how single-cell multimodal sequencing enables genotype–phenotype mapping and, when combined with phylogenetic reconstruction, provide insights into clonal evolution, cell state plasticity, and cancer progression, revealing mutant-specific vulnerabilities and offering a framework to study somatic evolution across pre-malignant and malignant human tissues.
043
Reposted by Kimberly Luddy
Yale Cancer Center @yalecancer.bsky.social · 11/09/2026
A new study from @jeffreytownsend.bsky.social shows how ranking mutations by cancer effect size, not frequency alone, can surface rare, potentially high-impact variants overlooked by standard approaches. medicine.yale.edu/cancer/publi... @plosone.org @yalesph.bsky.social
medicine.yale.edu
Driver Mutations in Chinese Liver Cancer Ranked
This study identifies which mutations most strongly drive hepatocellular carcinoma—liver cancer—in Chinese patients by measuring each mutation's selective
063
Reposted by Kimberly Luddy
Paul Byrne @theplanetaryguy.com · 09/09/2026
Astrophotographer Adam (AJ) Smadi caught this image a few hours ago from Washington state. A thin crescent Moon, sunlight illuminating the rugged lunar surface. And 2,400 times farther away—and on the other side of the Sun—mighty Jupiter, and its moons Io (left) and Ganymede (right).
A crescent Moon seen during the day, arcing from upper left to lower right of the frame. At lower centre is the full disk of Jupiter; the small dots to its upper left and lower right and Io and Ganymede, respectively.
187165415085
Kimberly Luddy @kimberly-luddy.bsky.social · 10/07/2026
I keep thinking about this paper by @rrockne.bsky.social and others at City of Hope. This feels foundational in a way I can't explain yet. Ligand discrimination in immune cells: Signal processing insights into immune dysfunction in ER+ breast cancer journals.plos.org/ploscompbiol...
journals.plos.org
Ligand discrimination in immune cells: Signal processing insights into immune dysfunction in ER+ breast cancer
Author summary Approximately 40% of estrogen receptor-positive breast cancer patients have problems in immune cell signaling at diagnosis, which can affect survival. This study introduces a new method...
030
Reposted by Kimberly Luddy
Waggoner Lab @labwaggoner.bsky.social · 25/06/2026
Based on a new NOA recieved this month, we are looking for a postdoctoral fellow with solid foundation of molecular skills, creativity, and translational passion to help us develop innovative CARs for targeting discrete subsets of T cells. DM or email me if interested
11513
Kimberly Luddy @kimberly-luddy.bsky.social · 16/06/2026
Are biological systems poised at criticality? arxiv.org/abs/1012.2242
arxiv.org
Are biological systems poised at criticality?
Many of life's most fascinating phenomena emerge from interactions among many elements--many amino acids determine the structure of a single protein, many genes determine the fate of a cell, many neur...
020
Reposted by Kimberly Luddy
John Attridge @johnattridge.bsky.social · 11/06/2026
Academic writing should be addressed neither to the public nor to other academics. It should be addressed to a single interlocutor with whom you have a petty rivalry and whose work you are trying to discredit
381723280
Reposted by Kimberly Luddy
bioRxiv Immunology @biorxiv-immuno.bsky.social · 09/05/2026
TIGIT-NECTIN2/3 signaling preserves ignorant CD8⁺ T cells for favorable immune checkpoint outcomes in HBV-related hepatocellular carcinoma www.biorxiv.org/content/10.64898/20…
011
Reposted by Kimberly Luddy
Waggoner Lab @labwaggoner.bsky.social · 23/04/2026
One-step knock-in CAR constructs in human NK cells enable scalable, TGFβ1-resistant immunotherapy for solid tumors www.thno.org/v16p5609.htm
022
Reposted by Kimberly Luddy
International Society for Evolution, Medicine & Public Health @evmed.bsky.social · 20/04/2026
The Evolution, Medicine, and Public Health journal welcomes submissions on infectious disease evolution, life history theory and health, evolutionary psychiatry, cancer evolution, and more. Have research at the intersection of evolution and health? Consider submitting: academic.oup.com/emph
academic.oup.com
Evolution, Medicine, and Public Health | Oxford Academic
The official journal of the International Society for Evolution, Medicine, and Public Health. An open access, multidisciplinary journal that publishes original, rigorous applications of evolutionary…
011
Reposted by Kimberly Luddy
Jia (Jenny) Liu MD PhD @jiajennyliu.bsky.social · 01/04/2026
The TIGIT catastrophe‼️ 30 agents 220 trials ~50,000 patients >$3B+ invested 0 approvals. This is herding in drug development. In BMJ Oncol we examine why it happens, the hidden costs, and what needs to change. It’s already happening again in ADCs... 🔗: t.co/dvbS49jGkF
042
Reposted by Kimberly Luddy
Nature Reviews Cancer @natrevcancer.nature.com · 06/03/2026
dlvr.it
Re-routing IgE for cancer therapy
Nature Reviews Cancer, Published online: 06 March 2026; doi:10.1038/s41568-026-00917-zIn a study published in Cell, Xu et al. show that mast cells engineered with tumour-antigen specific antibodies and loaded with an oncolytic virus can be activated by antigen encounter to drive targeted tumour cell killing and amplify local anti-tumour immunity.
001
Reposted by Kimberly Luddy
The American Association of Immunologists @aai.org · 05/03/2026
Don't miss this incredible opportunity! Register for IMMUNOLOGY2026™ in Boston, MA today and experience world-class science with the best in the field of #immunology. 🐦‍⬛ Early-bird registration ends March 13: immunology2026.aai.org.
032
Reposted by Kimberly Luddy
British Society for Immunology @britsocimm.bsky.social · 24/02/2026
Master complex multiparameter flow cytometry with confidence! Join our course led by trainer Derek Davies & learn how to design robust experiments, troubleshoot issues & generate reliable data using real immunology examples. 11 & 18 May, Register now: bit.ly/4qip05l
041
Reposted by Kimberly Luddy
British Society for Immunology @britsocimm.bsky.social · 12/02/2026
🧬 Have you submitted your abstract for #UKimmunomet26? The deadline is approaching in 3 weeks! Join the UK’s leading immunometabolism meeting in NCL for cutting edge research, international speakers & sessions for ECRs. Find out more & register 🔗 bit.ly/493uE45
035
Reposted by Kimberly Luddy
Nature Reviews Cancer @natrevcancer.nature.com · 09/02/2026
🥳 Our 5th most downloaded #REVIEW in 2025: Cross-priming in cancer immunology and immunotherapy #TME #immunotherapy @NatResCancer #NRCtop10of2025
dlvr.it
Cross-priming in cancer immunology and immunotherapy - Nature Reviews Cancer
In this Review, Luri-Rey et al. present evidence for the crucial role of conventional type 1 dendritic cells in cross-presenting antigens from other cells via the major histocompatibility complex class I antigen-presenting machinery, which in turn is necessary to prime CD8+ T cells, which then mount efficient immune responses against cancer. The authors also discuss how we can exploit these processes in cancer immunotherapy by increasing the number and/or maturation or activation status of this specialist subtype of antigen-presenting cell.
035
Reposted by Kimberly Luddy
Nature Reviews Cancer @natrevcancer.nature.com · 20/01/2026
dlvr.it
Tumour explants as next-generation models of cancer
Nature Reviews Cancer, Published online: 20 January 2026; doi:10.1038/s41568-026-00907-1To preserve tumour architecture, cellular heterogeneity and the dynamic crosstalk that influences cancer, Fong and colleagues advocate for coordinated, cross-disciplinary and sustained efforts to promote the widespread adoption of tumour explants.
032
Reposted by Kimberly Luddy
Waggoner Lab @labwaggoner.bsky.social · 23/12/2025
Leukemia-driven expansion of ILC3 facilitates a pro-tumoral microenvironment in acute myeloid leukemia #AML @ohiostatemed.bsky.social www.nature.com/articles/s41...
042
Reposted by Kimberly Luddy
Waggoner Lab @labwaggoner.bsky.social · 11/12/2025
Double stranded RNA sensing is silenced during early embryonic development @natcomms.nature.com @edinburghup.bsky.social www.nature.com/articles/s41...
064
Kimberly Luddy @kimberly-luddy.bsky.social · 09/12/2025
NSD2 targeting reverses plasticity and drug resistance in prostate cancer www.nature.com/articles/s41...
nature.com
NSD2 targeting reverses plasticity and drug resistance in prostate cancer - Nature
Inhibition of the histone methyltransferase NSD2 and the androgen receptor in preclinical models can reverse lineage plasticity to suppress tumour growth and promote cell death in multiple subtypes of...
000
Reposted by Kimberly Luddy
Itai Yanai @itaiyanai.bsky.social · 09/12/2025
There’s an art to writing a grant proposal so that your creativity is on full display. Maria Leptin - president of the ERC - talks about it on the new episode of the Night Science Podcast.
24511
Reposted by Kimberly Luddy
Bryan Bryson @thebrysonlab.bsky.social · 07/12/2025
The @ragoninstitute.bsky.social is launching a new faculty search for a computational immunologist! Applications are open now and reviewed on a rolling basis. Please share broadly with your networks! #immunosky www.nature.com/naturecareer...
nature.com
Computational Immunologist - Boston, Massachusetts (US) job with Ragon Institute of MGH, MIT, & Harvard | 12849577
The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard in Cambridge MA, together with the Departmen
01620
Reposted by Kimberly Luddy
Ben Hall @hallben.bsky.social · 08/12/2025
Very excited to announce that MSc computational cancer is now open for applications! A new joint programme from UCL engineering & cancer institute. Teaching #cancer through a computational lens, integrating cutting edge research with taught components. Apply below! www.ucl.ac.uk/prospective-...
ucl.ac.uk
Computational Cancer MSc
Be part of the revolution in cancer research and computational science with this interdisciplinary Master’s at UCL. Delivered jointly by UCL Medical Physics and Biomedical Engineering and the UCL Cancer Institute, this programme equips you with cutting-edge skills at the forefront of healthcare innovation.
044
Reposted by Kimberly Luddy
I-75 Scientist @flscitriguy.bsky.social · 03/12/2025
Updates to the submission process for LOIs and grants requesting more than $500K in any budget periods. grants.nih.gov/grants/guide...
grants.nih.gov
NOT-OD-26-019: Updated Application Policies: NIH Administrative Burden Reduction Effort Removal of Requirements for Letters of Intent and Unsolicited Applications Requesting $500,000 or More in Dire...
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Updated Application Policies: NIH Administrative Burden Reduction Effort Removal of Requirements for Letters of Inten...
177
Reposted by Kimberly Luddy
Richard Sever @richardsever.bsky.social · 04/12/2025
UKRI exploring use of AI in grant review - this will prompt debate but interested to know if people think it’d encourage novelty or the opposite? www.chemistryworld.com/news/ukri-op...
chemistryworld.com
UKRI opens up grant proposal data to explore using AI to smooth peer review
Surging applications has led the UK's main funder to look at ways to reduce the burden on reviewers
18510
Reposted by Kimberly Luddy
Itai Yanai @itaiyanai.bsky.social · 11/08/2025
The creative process in science has a set of thinking tools that we could do a better job teaching. Here are the 12 articles that Martin and I wrote about them, including "It takes two to think", "A hypothesis is a liability" and "The two languages of science". night-science.org/home/learn/r...
410926
Kimberly Luddy @kimberly-luddy.bsky.social · 05/08/2025
The DNA replication checkpoint targets the kinetochore to reposition DNA structure-induced replication damage to the nuclear periphery www.cell.com/cell-reports...
cell.com
The DNA replication checkpoint targets the kinetochore to reposition DNA structure-induced replication damage to the nuclear periphery
Expanded CAG repeats, the cause of Huntington’s disease, stall replication and reposition to the nuclear periphery to effect repair. Maclay et al. report that the DNA replication checkpoint targets th...
010
Reposted by Kimberly Luddy
Jie Yang @jieyang437.bsky.social · 18/07/2025
We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis. Deadline: 11 August 2025 my.corehr.com/pls/uoxrecru... Lab info: www.oncology.ox.ac.uk/team/jie-yang
my.corehr.com
Job Details
059
Reposted by Kimberly Luddy
Paul Macklin @mathcancer.bsky.social · 29/07/2025
Nice writeup of our new @cp-cell.bsky.social article on an intuitive, plain language "grammar" to make simulation modeling of complex multicellular systems more accessible. Huge thx to Forest Ray and @genomeweb.bsky.social ! Joint work by @fertiglab.bsky.social, Genevieve Stein-O'Brien & team! 🧪
1113
Reposted by Kimberly Luddy
Waggoner Lab @labwaggoner.bsky.social · 28/07/2025
Differentiation-associated ISG expression of NK cells in chronic viral infection @cp-iscience.bsky.social www.cell.com/iscience/ful...
152
Reposted by Kimberly Luddy
Waggoner Lab @labwaggoner.bsky.social · 25/07/2025
Review of the possible role of Matzinger's "danger theory" of damage-associated molecular patterns in CNS as drivers of increased incidence of major depressive disorder www.science.org/doi/10.1126/...
0119
Reposted by Kimberly Luddy
Chrystal Paulos @chrystalpaulos.bsky.social · 25/07/2025
🧵1/ New in @Cancer_Cell: Our lab discovered that Th17 cells must team up with B cells to eliminate tumors, and prevent it from coming back. 🔗 Read: www.cell.com/cancer-cell/... 🧬This unexpected immune duo sparks tumor immunity. 🖼️Image: See schematic Th17/B cell antitumor action!
cell.com
Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity
Cole et al. report that adoptively transferred, tumor-specific Th17 cells engage host B cells and drive B cell proliferation and differentiation. These Th17 cells require B cells for sustained immunit...
12913
Kimberly Luddy @kimberly-luddy.bsky.social · 08/07/2025
This announcement from the NIH is fantastic “NIH will no longer seek proposals exclusively for animal models” All new proposals should include modern alternatives: e.g. computational modeling and organoid style technologies with human components. drugdiscoverytrends.com/nih-announces-…
020
Reposted by Kimberly Luddy
Parmvir K Bahia @parmvir.com · 07/07/2025
A week away from the start of the @smbmathbiology.bsky.social meeting in #Edmonton so it seems like an apt time to share my convo with conference organizer, Jay Newby. You'll also hear me nerding out about potassium channels in neurons 🧠 smb.org/news/13516785 #SciencePodcast #BiologyInNumbers
054
Reposted by Kimberly Luddy
Nature Reviews Drug Discovery @natrevdrugdiscov.nature.com · 27/06/2025
Metabolites as agents and targets for cancer immunotherapy www.nature.com/articles/s41... rdcu.be/etLMD This new Review discusses the role of metabolic pathways in cancer and immune cells in shaping the tumour microenvironment, and how they can be targeted to improve anticancer immune responses
nature.com
Metabolites as agents and targets for cancer immunotherapy  - Nature Reviews Drug Discovery
Tumour cells undergo profound changes in their metabolism, but targeting these metabolic pathways requires understanding of the impact on immune cells as well as cancer cells. This Review discusses ho...
2124
Reposted by Kimberly Luddy
British Society for Immunology @britsocimm.bsky.social · 26/06/2025
🔥 Dive into the latest on inflammasomes, innate immunity & more at our event with the BSI #Inflammation Affinity Group on 11–12 Sept in Manchester! Cutting-edge talks, career workshops & networking with experts. Abstract deadline: 15 July! ☑️ Submit your abstract & register: bit.ly/43q9x9r
021
Kimberly Luddy @kimberly-luddy.bsky.social · 06/05/2025
Sarah Amend: Describing endocyling in cancer dormancy starts by highlighting the lethality of metastatic + therapy resistant cancer cells.
020
Kimberly Luddy @kimberly-luddy.bsky.social · 06/05/2025
Guido Ferlazzo: Hepatic stellate cells facilitate the regrowth of dormant cancer cells by reducing NK cell regulation of dormancy in the liver.
000
Kimberly Luddy @kimberly-luddy.bsky.social · 06/05/2025
Kenneth Pienta: Detecting prostate cancer metastasis with PSMA has changed his understanding of the metastatic cascade.
000
Kimberly Luddy @kimberly-luddy.bsky.social · 06/05/2025
Day 2 of Cancer Dormancy and Therapy Resistance workshop.
000
Kimberly Luddy @kimberly-luddy.bsky.social · 05/05/2025
Alessandra Riggio, discussing a rapid autopsy program in metastatic breast cancer. Finding disseminated cells undetectable by imaging.
010
Kimberly Luddy @kimberly-luddy.bsky.social · 05/05/2025
Simone Baldassarri: Mathematical aspects of Dormancy for non experts. Dormancy and migration slow gentic drift and enhance diversity
100
Kimberly Luddy @kimberly-luddy.bsky.social · 05/05/2025
Ann Zeuner asks, is Cancer Dormancy a Trojan horse or an Achille's heel?
010
Kimberly Luddy @kimberly-luddy.bsky.social · 05/05/2025
Looking forward to a great conference on Cancer Dormancy and Therapy Resistance.
100
Reposted by Kimberly Luddy
Trends in Immunology @cp-trendsimmuno.bsky.social · 26/02/2025
Helper ILCs in the human hematopoietic system #immunology
dlvr.it
Helper ILCs in the human hematopoietic system
Helper innate lymphoid cells (ILCs), comprising groups ILC1, ILC2, and ILC3, possess unique advantages in eliciting rapid immune responses and were recently found to exhibit direct tumor-killing capacities comparable with those of cytotoxic ILCs [natural…
012
Reposted by Kimberly Luddy
Mary Canavan @mary-canavan.bsky.social · 17/01/2025
Absolutely delighted to receive this award from @researchireland.bsky.social as Highly Commended in the Early Career Researcher of the Year 2024! I'm so grateful to all of my colleagues &the wider research community for their support. Looking forward to continuing our research in 2025 & beyond!
191
Kimberly Luddy @kimberly-luddy.bsky.social · 21/01/2025
An important reminder: Science is really difficult. It's almost a daily conversation in the lab. Remember, 50% of what we do has never been done before. From the simplest experiments to the most indepth review. This stuff is not easy. Be kind and celebrate the wins!
030
Kimberly Luddy @kimberly-luddy.bsky.social · 21/01/2025
Today's Integrated Mathematical Oncology research in progess talk, Thomas Veith: Optimizing the Replicator Equation to Model Frequency Dependent Effects in cancer, when Selection favors the rare phenotype. #Oncology
130
Reposted by Kimberly Luddy
Adam Pennycuick @adampennycuick.bsky.social · 16/01/2025
"Liquid biopsies" detecting ctDNA have a lot of promise but have had poor sensitivity in early stage disease. Can new ultra-sensitive techniques overcome these challenges? Impressive data from the TRACERx team buff.ly/4jfMyF6 Found with researchbriefing.com
nature.com
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma - Nature Medicine
In the TRACERx cohort of 171 patients with lung cancer, the ultrasensitive detection of ctDNA improves preoperative patient stratification, also in early-stage disease.
062
Reposted by Kimberly Luddy
Adrian Liston @labliston.bsky.social · 12/01/2025
The single best career advice that I give PhDs is that there are multiple different pathways to success. It is the detours that make your insights unique. This is why @immunolcellbiol.bsky.social made #PathwaysToSuccess - get inspired from different journeys! onlinelibrary.wiley.com/page/journal...
onlinelibrary.wiley.com
<em>Immunology & Cell Biology</em> | ASI Journal | Wiley Online Library
<em>Immunology & Cell Biology</em>  is the flagship journal of the ASI, focusing on the general functioning of the immune system, with particular emphasis on its cell biology.
15924